TissueGen to Exhibit and Present on Latest Advancement in Extrusion Technology for Drug Delivery Applications at MD&M East

28 May TissueGen to Exhibit and Present on Latest Advancement in Extrusion Technology for Drug Delivery Applications at MD&M East

Founder & CSO, Dr. Kevin Nelson’s Innovation Forum Session to take place on Wednesday, June 11th at 11:15am

WHO: TissueGen® Inc., developer of ELUTE® Biodegradable Drug-Loaded fiber—cutting-edge biodegradable polymer technology for implantable drug delivery across a wide variety of therapeutic applications.
WHAT:

The emergence of commercialized extrusion methods that occur at room temperature is enabling drug-loading of a wider range of pharmaceutical and biological agents than ever before possible for use in biodegradable fiber-based implantable devices for localized drug delivery within the body.

At MD&M East, TissueGen will also be exhibiting its ELUTE® Biodegradable Drug-Loaded fiber in booth #1688. ELUTE BDL fibers are available in pharmaceutical and growth factor formats ideal for a wide variety of medical applications. Dr. Kevin Nelson, founder and CSO ofTissueGen,will also present a session titled “Latest Advancement in Extrusion Technology for Drug Delivery Applications.”

Dr. Nelson’s session will:

– Explore the latest advancement in extrusion technology which is enabling the next generation of drug delivery.

– Examine medical applications that stand to be most significantly impacted by this technological advancement.

WHERE:

MD&M East
Booth 1688
Jacob K. Javits Convention Center
New York, NY

WHEN: MD&M East will take place from June 10-12, 2014. Dr. Nelson’s session will be held on Wednesday, June 11th at 11:15am as part on Innovation Forum Track 2.

To schedule a briefing, please contact Jordan Bouclin at Jordan.bouclin@svmpr.com or (401)490-9700.

 

About TissueGen

TissueGen® Inc., developer of ELUTE® Biodegradable Drug-Loaded fiber, has more than four decades of cumulative experience in extruding biodegradable polymer fibers with broad drug delivery capabilities. TissueGen offers the medical market innovative technology built upon a portfolio of issued patents for unique drug delivery including the ability to incorporate and elute a broad range of therapeuticsandstandard pharmaceuticals in hydrophobic polymeric fibers or tubes for sustained therapeutic release. For more information, please visit www.tissuegen.com/.

# # #

 

For more information contact:

Jordan Bouclin
SVM Public Relations
401-490-9700
jordan.bouclin@svmpr.com

 

198 Comments

Sorry, the comment form is closed at this time.